Navigation Links
Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
Date:12/3/2007

SEATTLE, Dec. 4 /PRNewswire/ -- The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit scientific research institute, announced today that it has received a $29,947,850 five year grant from the Bill & Melinda Gates Foundation. The grant will be used to provide adjuvants (essential components for many vaccines) for priority malaria vaccine candidates. Advances arising from this project are likely also to facilitate development of vaccines against other neglected diseases.

Adjuvants are vaccine components that, when appropriately formulated and combined with an antigen, direct the immune system to give an effective response while boosting the potency and longevity of the specific immune responses. Most adjuvants are owned by large pharmaceutical companies and not easily accessible to researchers developing vaccines for neglected diseases. IDRI seeks to provide the public sector with safe, effective, low-cost adjuvants through component testing and licensing, product improvement, development of adjuvant-antigen formulations, and the creation of an adjuvant library.

With this grant, IDRI will focus on adjuvants for malaria vaccines. Because malaria parasites have a complex life cycle, creating an effective vaccine is a major scientific challenge. Worldwide, every year between 350 million and 500 million people are infected with malaria and more than 1 million die from this preventable disease. To accelerate the fight against malaria, IDRI will obtain access to adjuvants with proven clinical potential in malaria vaccines and will develop next-generation adjuvant formulations for malaria vaccine candidates.

"This grant enables IDRI to help advance the development of malaria vaccines," said Dr. Steven Reed, Founder and Head of IDRI's Research and Development Program. "We are honored that the Gates Foundation has provided this opportunity and look forward to working with researchers in the field of malaria."

IDRI, in partnership with the World Health Organization in Geneva, will work closely with the PATH Malaria Vaccine Initiative and other agencies and investigators to select priority malaria antigens for preliminary development and testing of these adjuvant formulations.

About IDRI

IDRI is a non-profit organization committed to developing technologies to treat "neglected" diseases that place a significant burden on those living in the developing world. IDRI achieves its mission by working closely with industry, universities, and hospitals in developed and developing countries, government and private funding agencies, and the World Health Organization. For more information, go to http://www.idri.org.


'/>"/>
SOURCE The Infectious Disease Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. Infectious diseases experts applaud bill against bad bugs
3. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
4. Einstein scientists treat cancer as an infectious disease -- with promising results
5. Northwestern exposing most deadly infectious diseases in 3-D
6. Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham
7. Study shows suppressing herpes virus may reduce infectiousness of HIV
8. Infectious Diseases Institute Appoints Alex Coutinho, M.D as Executive Director
9. Smoking may strongly increase long-term risk of eye disease
10. Pot bellies linked to early signs of cardiovascular disease
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... 16, 2017 , ... With the Grand Opening Event planned for February 3, ... sports teams and the general public. Built in five months by Centerpoint, the 60,000 ... into basketball or pickleball courts. The space is also suitable for indoor soccer and ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... their recent partnership with an innovator in the wheelchair accessibility industry, BraunAbility ... their dealer salespeople to sell wheelchair accessible vehicles. With this new incentive plan, ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Aesthetic Surgery Journal , the official journal of The American Society for Aesthetic ... retraction surgery. The procedure is designed to correct drooping, retracted lower eyelids, which ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)...  This report by Persistence Market Research examines ... the period 2016–2024. The primary objective of the ... to market opportunities in the global peripherally inserted ... the various dynamics that are expected to influence ... global peripherally inserted central catheters market over the ...
(Date:1/16/2017)... 2017   The Harrington Discovery Institute ... , has announced the 2017 recipients of ... of physician-scientists whose research shows promise to advance ... Discovery Institute – part of The Harrington Project ... in academic medicine: to advance early breakthroughs into ...
(Date:1/16/2017)... PORTLAND, Oregon and PUNE, India ... report published by Allied Market Research, titled, "Vital Signs Monitoring ... and Industry Forecast, 2014-2022", projects that the global vital signs ... and is expected to reach $5,491 million by 2022, growing ... North America was the leading regional market ...
Breaking Medicine Technology: